Delivery Order SPE2DB20D1100-SPE2DB24FC4P7

Award Date 6/26/24
Potential Completion Date 7/18/24
Potential Value $33K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,344.30, is for the delivery of LORBRENA 100 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 18, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,344.30 firm fixed-price delivery order is for the supply of LORBRENA 100 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of April 22, 2025 and was awarded on April 1, 2025. This appears to be a part of a larger Indefinite Delivery...
This federal contract award, with a ceiling value of $21,156.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $21,930.68 firm fixed price Delivery Order is for the pharmaceutical product LORBRENA 100 MG TABLET 30S, with a completion date of July 5, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of LORBRENA 100 MG TABLET 30S. The contract has an award value of $21,156.78 and a completion date of February 20, 2024. It is a Delivery Order contract with a Firm Fixed Price pricing type, awarded by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,930.68, is a Delivery Order for the supply of the pharmaceutical drug LORBRENA 100 MG TABLET 30S. The award has an Ultimate Completion Date of November 8, 2024. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,344.30, is for the supply of LORBRENA 100 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2025 and is a firm fixed-price contract. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,688.62 firm fixed price delivery order is for the drug LORBRENA 100 MG TABLET 30S, with a performance period ending on April 9, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,688.62 firm fixed-price delivery order is for the supply of LORBRENA 100 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of March 25, 2025. No set-aside designation was used for this award. AmerisourceBergen holds a $999,999,999...
This federal contract award is between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LORBRENA 100 MG TABLET 30S, a prescription medication. The award has a ceiling value of $21,930.68 and an ultimate completion date of September 19, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded this Firm Fixed Price delivery order contract to supply the...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC4P7
    Delivery Order

This federal contract award, valued at $32,895.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of LORBRENA 100 MG TABLET 30S. The contract is a Firm Fixed Price Delivery Order with a completion date of July 18, 2024.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This contract award was made on a full and open competition basis without any set-aside designations.

Generated 9/25/24, 9:27 AM